Frantisek Salajka
- Use of erlotinib in management of advanced non-small cell lung cancer (NSCLC): The Czech Republic experience with the treatment of a non-selected population of 1735 patients (pts)By Jana Skrickova, Milos Pesek, Petr Zatloukal, Vitezslav Kolek, Frantisek Salajka, Leona Koubkova, Jana Krejci, Marcela Tomiskova, Grygarkova Ivona and Michal HrnciarikJana Skrickova1Dept. of Respiratory Diseases and TB, University Hospital Brno, Brno, Czech RepublicMilos Pesek2Dept. of Respiratory Diseases and TB, University Hospital Plzen, Plzen, Czech RepublicPetr Zatloukal3Dept. of Respiratory Diseases and TB, University Hospital Bulovka, Praha, Czech RepublicVitezslav Kolek4Dept. of Respiratory Diseases and TB, University Hospital Olomouc, Olomouc, Czech RepublicFrantisek Salajka5Dept. of Respiratory Diseases, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicLeona Koubkova6Dept. of Respiratory Diseases, University Hospital Praha Motol, Praha, Czech RepublicJana Krejci3Dept. of Respiratory Diseases and TB, University Hospital Bulovka, Praha, Czech RepublicMarcela Tomiskova1Dept. of Respiratory Diseases and TB, University Hospital Brno, Brno, Czech RepublicGrygarkova Ivona4Dept. of Respiratory Diseases and TB, University Hospital Olomouc, Olomouc, Czech RepublicMichal Hrnciarik5Dept. of Respiratory Diseases, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosisBy František Salajka, Vladimír Bartoš, Jakub Novosad, Josef Štásek, Josef Bis, Miroslav Brtko, Pavel Polanský, Vladimír Koblízek and Vratislav SedlákFrantišek Salajka1Department of Pneumology, Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech RepublicVladimír Bartoš1Department of Pneumology, Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech RepublicJakub Novosad2Department of Clinical Immunology and Allergology, Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech RepublicJosef Štásek3First Department of Internal Medicine, Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech RepublicJosef Bis3First Department of Internal Medicine, Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech RepublicMiroslav Brtko4Department of Cardiosurgery, Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech RepublicPavel Polanský4Department of Cardiosurgery, Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech RepublicVladimír Koblízek1Department of Pneumology, Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech RepublicVratislav Sedlák1Department of Pneumology, Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech Republic
- Pemetrexed in the first line treatment in non-small cell lung cancer (NSCLC): A multicentre prospective analysis of data from clinical practise of Czech RepublicBy Jana Skrickova, Karel Hejduk, Zbynek Bortlicek, Milos Pesek, Vitezslav Kolek, Leona Koubkova, Petr Zatloukal, Frantisek Salajka, Milada Zemanova, Dimka Sixtova, Jaromir Roubec and Helena CoupkovaJana Skrickova1Department of Respiratory Diseases and TB, University Hospital, Brno, Czech RepublicKarel Hejduk2Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicZbynek Bortlicek2Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicMilos Pesek3Department of Respiratory Diseases and TB, University Hospital, Plzen, Czech RepublicVitezslav Kolek4Department of Respiratory Diseases and TB, University Hospital, Olomouc, Czech RepublicLeona Koubkova5Department of Respiratory Diseases and TB, University Hospital Motol, Praha, Czech RepublicPetr Zatloukal6Department of Respiratory Diseases and TB, University Hospital Bulovka, Praha, Czech RepublicFrantisek Salajka7Department of Respiratory Diseases and TB, University Hospital, Hradec Kralove, Czech RepublicMilada Zemanova8Oncology Department, Charles University Hospital, Praha, Czech RepublicDimka Sixtova9Department of Respiratory Diseases and TB, Thomayer Hospital, Praha, Czech RepublicJaromir Roubec10Department of Respiratory Diseases and TB, Faculty Hospital, Ostrava, Czech RepublicHelena Coupkova11Oncology Department, Masaryk Memorial Institute, Brno, Czech Republic
- Gefitinib in front line treatment of patients with NSCLC in the Czech Republic: Analysis of 113 patientsBy Jana Skrickova, Zdenek Bortlicek, Karel Hejduk, Milos Pesek, Vitezslav Kolek, Leona Koubkova, Marcela Tomiskova, Jaromir Roubec, Libor Havel, Frantisek Salajka, Ivona Grygarkova, Michal Hrnciarik, Monika Satankova, Zdenka Povolna, Marketa Cernovska, Miloslav Marel and Martina VasakovaJana Skrickova1Department of Respiratory Diseases and TB, University Hospital and Faculty of Medicine, Brno, Czech RepublicZdenek Bortlicek2Instutute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicKarel Hejduk2Instutute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicMilos Pesek3Deparment of TB and Respiratory Diseases, University and Faculty Hospital Plzen, Plzen, Czech RepublicVitezslav Kolek4Department of Respiratory Diseases and TB, University and Faculty Hospital Plzen, Olomouc, Czech RepublicLeona Koubkova5Department of Respiratory Diseases and TB, University and Faculty Hospital Praha - Motol, Praha, Czech RepublicMarcela Tomiskova1Department of Respiratory Diseases and TB, University Hospital and Faculty of Medicine, Brno, Czech RepublicJaromir Roubec6Deparment of TB and Respiratory Diseases, Faculty Hospital Ostrava, Ostrava, Czech RepublicLibor Havel7Department of Respiratory Diseases and TB, Faculty Hospital Bulovka, Praha, Czech RepublicFrantisek Salajka8Department of Respiratory Diseases, Faculty Hospital Hraed Kralove, Hradec Kralove, Czech RepublicIvona Grygarkova4Department of Respiratory Diseases and TB, University and Faculty Hospital Plzen, Olomouc, Czech RepublicMichal Hrnciarik8Department of Respiratory Diseases, Faculty Hospital Hraed Kralove, Hradec Kralove, Czech RepublicMonika Satankova1Department of Respiratory Diseases and TB, University Hospital and Faculty of Medicine, Brno, Czech RepublicZdenka Povolna1Department of Respiratory Diseases and TB, University Hospital and Faculty of Medicine, Brno, Czech RepublicMarketa Cernovska9Department of Respiratory Diseases and TB, Thomayer Faculty Hospital, Praha, Czech RepublicMiloslav Marel5Department of Respiratory Diseases and TB, University and Faculty Hospital Praha - Motol, Praha, Czech RepublicMartina Vasakova9Department of Respiratory Diseases and TB, Thomayer Faculty Hospital, Praha, Czech Republic
- Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech RepublicBy Jana Skrickova, Zbynek Bortlicek, Karel Hejduk, Milos Pesek, Vitezslav Kolek, Leona Koubkova, Jaromir Roubec, Libor Havel, Frantisek Salajka, Marcela Tomiskova and Monika SatankovaJana Skrickova1Department of Respiratory Medicine and TB, Hospital Brn and, Medical Faculty of Masaryk University, Brno, Czech RepublicZbynek Bortlicek2Institute of Biostatistics and Analyses, Masaryk University Brno, Brno, Czech RepublicKarel Hejduk2Institute of Biostatistics and Analyses, Masaryk University Brno, Brno, Czech RepublicMilos Pesek3Department of Tuberculosis and Respiratory Diseases, University Hospital Plzen, Plzen, Czech RepublicVitezslav Kolek4Department of Pulmonary Diseases and Tuberculosis, University Hospital Olomouc, Olomouc, Czech RepublicLeona Koubkova5Department of Pulmonary Medicine, University Hospital in Motol, Prague, Czech RepublicJaromir Roubec6Department of Tuberculosis and Respiratory Diseases, University Hospital Ostrava, Ostrava, Czech RepublicLibor Havel7Department of Pulmonary Medicine, University Hospital Bulovka, Prague, Czech RepublicFrantisek Salajka8Department of Pulmonary Medicine, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicMarcela Tomiskova1Department of Respiratory Medicine and TB, Hospital Brn and, Medical Faculty of Masaryk University, Brno, Czech RepublicMonika Satankova1Department of Respiratory Medicine and TB, Hospital Brn and, Medical Faculty of Masaryk University, Brno, Czech Republic
- A liquid chromatography MS/MS metabolomics study of COPD patientsBy Barbora Novotna, Mohammed Abdel-Hamid, Vladimir Koblizek, Jiri Jarkovsky, Karel Hejduk, Vit Rehacek, Josef Bis and Frantisek SalajkaBarbora Novotna1Department of Pneumology, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicMohammed Abdel-Hamid2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait University, Kuwait City, KuwaitVladimir Koblizek1Department of Pneumology, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicJiri Jarkovsky3Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicKarel Hejduk3Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicVit Rehacek4Department of Transfusions, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicJosef Bis5Department of Cardio-Angiology, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicFrantisek Salajka1Department of Pneumology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- Cardiovascular status of patients with a severe form of COPDBy Barbora Novotna, Vladimir Koblizek, Michal Svoboda, Jan Svancara, Karel Hejduk, Jiri Jarkovsky, Michal Kopecky, Rudolf Praus, Zuzana Zbozinkova, Marek Putinsky, Jaromir Zatloukal, Patricie Popelkova, Tomas Dvorak, Petr Safranek, Ondrej Sobotik, Alena Vlachova, Petr Vanik, Zuzana Liptakova, Lucie Heribanova, Blanka Snelerova, Pavlina Musilova, Maria Majerciakova, Tomas Vencalek, Eva Kocova, Onderj Kudela, Katerina Neumannova, Kristian Brat, Eva Volakova and Frantisek SalajkaBarbora Novotna1Department of Pneumology, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicVladimir Koblizek1Department of Pneumology, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicMichal Svoboda2Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicJan Svancara2Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicKarel Hejduk2Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicJiri Jarkovsky2Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicMichal Kopecky1Department of Pneumology, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicRudolf Praus3Department of Cardioangiology, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicZuzana Zbozinkova2Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech RepublicMarek Putinsky4Department of Pneumology, University Hospital Brno, Brno, Czech RepublicJaromir Zatloukal5Department of Pneumology, University Hospital Olomouc, Olomouc, Czech RepublicPatricie Popelkova6Department of Pneumology, University Hospital Ostrava, Ostrava, Czech RepublicTomas Dvorak7Department of Pneumology, Bulovka Hospital, Prague, Czech RepublicPetr Safranek8Department of Pneumology, University Hospital Plzen, Plzen, Czech RepublicOndrej Sobotik9Department of Pneumology, University Hospital Motol, Prague, Czech RepublicAlena Vlachova9Department of Pneumology, University Hospital Motol, Prague, Czech RepublicPetr Vanik10Department of Pneumology, Regional Hospital Ceske Budejovice, Ceske Budejovice, Czech RepublicZuzana Liptakova10Department of Pneumology, Regional Hospital Ceske Budejovice, Ceske Budejovice, Czech RepublicLucie Heribanova11Department of Pneumology, Thomayer Hospital, Prague, Czech RepublicBlanka Snelerova12Department of Pneumology, Masaryk Regional Hospital, Usti nad Labem, Czech RepublicPavlina Musilova13Department of Pneumology, Regional Hospital Jihlava, Jihlava, Czech RepublicMaria Majerciakova14Depertment of Pneumology, Regional Hospital T.Bata, Zlin, Czech RepublicTomas Vencalek15Department of Pneumology, Regional Hospital Liberec, Liberec, Czech RepublicEva Kocova16Department of Radiology, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicOnderj Kudela1Department of Pneumology, University Hospital Hradec Kralove, Hradec Kralove, Czech RepublicKaterina Neumannova17Faculty of Physical Culture, Palacky University, Olomouc, Czech RepublicKristian Brat4Department of Pneumology, University Hospital Brno, Brno, Czech RepublicEva Volakova5Department of Pneumology, University Hospital Olomouc, Olomouc, Czech RepublicFrantisek Salajka1Department of Pneumology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.